Iridex Announces Strategic Collaboration with Topcon Corporation
Transaction provides $19.5 million cash to Iridex, as two leaders join forces in glaucoma and retinal disease treatmentIridex to host a conference call presentation on March 2, 2021 at 2:00 p.m. PT/5:00 p.m. ET MOUNTAIN VIEW, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that it has entered into a strategic collaboration with Topcon Corporation. Topcon is a Japanese-based manufacturer and distributor with approximately $1.3 billion in annual revenues, including $430 million from its eye care business. Highlights of the ne
